Zynerba Pharmaceuticals, Inc.
USD1.30
+0.03 (+2.36%)
CEO
Armando Anido MBA
IPO Date
2015-08-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$1.26
Prev. Close
$1.27
Day Low
$1.26
Day High
$1.34
52W Low
$0.25
52W High
$1.40
Market Cap
$0.07B
Volume
0.86M
| -3.0 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -83.8% | -68.1% | 0.00 | 5.27 | -1.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -41.6% | -35.8% | 0.00 | 7.22 | -4.2 |
| 31 Dec 2018 | FY | 100.0% | -46408.3% | -69.3% | -59.3% | 0.00 | 6.88 | -1.1 |
| 31 Dec 2017 | FY | 100.0% | -441549.0% | -52.5% | -46.4% | 0.00 | 9.17 | -5.1 |
| 31 Dec 2016 | FY | 100.0% | -322600.1% | -79.0% | -64.0% | 0.00 | 5.23 | -6.0 |
| 31 Dec 2015 | FY | 100.0% | -4500.3% | -31.6% | -28.8% | 0.00 | 11.03 | -3.6 |
| 31 Dec 2014 | FY | 100.0% | -699.9% | 70.4% | -48.8% | 0.00 | 3.69 | -16.4 |
| 31 Dec 2013 | FY | 100.0% | -67.5% | 53.2% | -34.2% | -0.42 | 0.44 | -146.3 |
| -0.5 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -16.5% | -13.7% | 0.01 | 5.97 | -0.8 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -16.8% | -14.2% | 0.01 | 6.45 | -0.9 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -18.4% | -15.7% | 0.01 | 6.89 | -1.1 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -13.0% | -11.4% | 0.01 | 8.21 | -2.4 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -12.4% | -10.9% | 0.01 | 8.10 | -3.3 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -13.4% | -11.8% | 0.01 | 8.08 | -4.0 |
| 30 Jun 2021 | Q2 | 0.0% | 0.0% | -11.3% | -10.1% | 0.01 | 9.62 | -5.3 |
| 31 Mar 2021 | Q1 | 0.0% | 0.0% | -8.3% | -7.3% | 0.01 | 8.53 | -5.9 |